Morgan Stanley: Teleflex's Management Remains Confident

In a research report published earlier today, Morgan Stanley commented that it is not as confident in Teleflex's TFX strategy as management is. According to Morgan Stanley, “Management meetings suggest confidence in the top line and commitment to investing in product differentiation. Teleflex's ability to reach 7% sales growth and 5% R&D spending long-term is less clear, but we are not convinced those levels are necessary to drive value.” Morgan Stanley maintains its Equal-weight rating on Teleflex, which closed yesterday at $61.24.